🇬🇧 United Kingdom MHRA

CJC-1295

Long-acting GHRH analogue that stimulates sustained growth hormone release

Research only available MHRA
Key stats Research
6-8 days
Half-life (DAC formulation)
GHRH
Mechanism class
Pituitary
Primary site of action
Phase 1/2
Human trial data available
🇬🇧 United Kingdom MHRA

🇬🇧 United Kingdom · MHRA

Legal status

🇬🇧 United Kingdom — MHRA
available

CJC-1295 is not approved for therapeutic use in United Kingdom. Not a controlled substance. Legal to purchase for research purposes under MHRA guidelines. Verify current status before ordering.

This website is intended for research and educational purposes only. The information provided does not constitute medical advice and should not be used to diagnose, treat, cure, or prevent any condition. Peptides discussed on this site are not approved by the MHRA for human therapeutic use. Always consult a qualified healthcare professional before using any substance.

Full legal guide for United Kingdom →

Frequently asked

Common questions

Is CJC-1295 legal in United Kingdom?

CJC-1295 is not approved for therapeutic use in United Kingdom and is not a controlled substance. It can be purchased for legitimate research purposes under MHRA guidelines.

Can I buy CJC-1295 in United Kingdom?

Research-grade CJC-1295 is available from vendors that ship to United Kingdom. It is not available from pharmacies as it has not received MHRA therapeutic approval.

Where to source CJC-1295

CJC-1295 in United Kingdom

We verify COA documentation and purity standards before listing any vendor.

Get vendor access →